Creating a vaccine for COVID-19
Development of a COVID-19 Vaccine
['FUNDING_OTHER'] · COLORADO STATE UNIVERSITY · NIH-10925117
This study is working on creating a new COVID-19 vaccine to make sure it's safe and effective for people, starting with tests in animals before it goes to human trials.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLORADO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (FORT COLLINS, UNITED STATES) |
| Trial ID | NIH-10925117 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a vaccine specifically for COVID-19, which includes formulating and manufacturing vaccine components. The approach involves testing the vaccine's stability and its ability to provoke an immune response in animal models before moving to human trials. The research aims to ensure the vaccine is safe and effective for use in response to the COVID-19 pandemic and similar infectious disease outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for COVID-19 or those living in areas with significant outbreaks.
Not a fit: Patients who are not at risk for COVID-19 or who have already been vaccinated may not receive additional benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a safe and effective vaccine that protects individuals from COVID-19 and potentially other emerging infectious diseases.
How similar studies have performed: Previous research on vaccine development for infectious diseases has shown significant success, indicating that this approach is both tested and promising.
Where this research is happening
FORT COLLINS, UNITED STATES
- COLORADO STATE UNIVERSITY — FORT COLLINS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOODRICH, RAYMOND — COLORADO STATE UNIVERSITY
- Study coordinator: GOODRICH, RAYMOND
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Emerging Infectious Diseases, Emerging Communicable Diseases, National Institute of Allergy and Infectious Disease